Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm

Completed

Conditions studied: Aortic Aneurysm, Abdominal

In brief

The purpose of this study is to better understand the role of inflammation in the pathophysiology of abdominal aortic aneurysm. In this study we hope to show better ways of predicting risk in this condition by using a combination of FDG-PET with CT.

Key facts

Study ID

NCT00513773

Run by

Vanderbilt University Medical Center

People needed

14

Starts

2008-07-01

Expected to finish

2014-02-01

Last updated by the study team

2017-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with AAA between 3 to 5 cm
• Patients with AAA > 5cm in whom the risk of operative intervention is prohibitive in the opinion of the surgeon.
• No allergies to iodinated contrast.
• Diabetic patients will be eligible for this study. Patient on metformin will be asked not to take the drug for one day prior to and for two days after the procedure.
• Subjects must be able to give informed consent

You may not qualify if…

• Patients with an impaired kidney function, significantly elevated creatinine levels after angiography/PCI (serum creatinine level >1.5 mg/dl) will be excluded form the study.
• Unstable patients or those with decompensated heart failure will be excluded because of safety reasons.
• Pregnant or lactating women will be excluded. Pregnancy will need to be tested in all pre-menopausal women.

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.